{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:58:22Z","timestamp":1790726302060,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe a methicillin-susceptible Staphylococcus aureus (MSSA) thigh abscess following alternate-site placement of a continuous glucose monitor (CGM) sensor and to highlight safety considerations associated with off-label device use in patients with poorly controlled diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A 49-year-old man with uncontrolled type 2 diabetes (glycated hemoglobin, 11.3%) was referred to an ambulatory care pharmacist for diabetes management. The patient placed the sensor on his upper thigh due to prior dislodgement from the upper arm. Three days later, the patient presented with a painful, erythematous, fluctuant 4.5 \u00d7 5\u2005cm abscess at the sensor insertion site. Initial incision and drainage (I&amp;D) was performed and oral sulfamethoxazole\/trimethoprim was prescribed. Four days later, he returned with worsening pain and impaired ambulation requiring repeat I&amp;D. Wound cultures grew MSSA. Management additionally included wound packing, topical mupirocin, and continuation of sulfamethoxazole\/trimethoprim, with clinical improvement noted after the second I&amp;D procedure. Cutaneous complications with CGM use are typically mild, infrequent, and most often involve contact or irritant dermatitis rather than infection. Reports of CGM-associated skin infections are rare, and none have been reported following sensor placement at unapproved insertion sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case underscores the potential for a skin and soft tissue infection following off-label CGM placement, especially in patients with uncontrolled hyperglycemia. Pharmacists play a critical role in reinforcing appropriate device use, identifying early signs of infection, and coordinating interdisciplinary care to mitigate device-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag252","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:05:41Z","timestamp":1787947541000},"source":"Crossref","is-referenced-by-count":0,"title":["Thigh abscess following alternate-site continuous glucose monitoring sensor placement"],"prefix":"10.1093","author":[{"given":"Kristy M","family":"Shaeer","sequence":"first","affiliation":[{"name":"University of South Florida Taneja College of Pharmacy , Tampa, FL, and University of South Florida Morsani College of Medicine, Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raechel T","family":"White","sequence":"additional","affiliation":[{"name":"University of South Florida Taneja College of Pharmacy , Tampa, FL, and University of South Florida Morsani College of Medicine, Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lord","sequence":"additional","affiliation":[{"name":"Piedmont Athens Regional, Athens , GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina L","family":"Pham","sequence":"additional","affiliation":[{"name":"Winter Haven Hospital, Winter Haven , FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kimble","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine , Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L","family":"Reynolds","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine , Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Teeters","sequence":"additional","affiliation":[{"name":"University of South Florida Morsani College of Medicine , Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cowart","sequence":"additional","affiliation":[{"name":"University of South Florida Taneja College of Pharmacy , Tampa, FL, University of South Florida Morsani College of Medicine, Tampa, FL, and University of South Florida College of Public Health, Tampa, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026092919063946600_zxag252-B1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"2026092919063946600_zxag252-B2","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"Diabetes technology: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","journal-title":"Diabetes Care"},{"key":"2026092919063946600_zxag252-B3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.japh.2023.07.010","article-title":"Pharmacist-driven continuous glucose monitoring in community and ambulatory care pharmacy practice: a scoping review","volume":"63","author":"Vascimini","year":"2023","journal-title":"J Am Pharm Assoc"},{"key":"2026092919063946600_zxag252-B4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/08971900211000273","article-title":"Flash continuous glucose monitoring: a practical guide and call to action for pharmacists","volume":"35","author":"Cowart","year":"2022","journal-title":"J Pharm Pract"},{"issue":"suppl 3","key":"2026092919063946600_zxag252-B5","first-page":"S81","article-title":"Health care disparities in use of continuous glucose monitoring","volume":"23","author":"Isaacs","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026092919063946600_zxag252-B6","author":"Abbott Diabetes Care"},{"key":"2026092919063946600_zxag252-B7","author":"Dexcom Inc"},{"key":"2026092919063946600_zxag252-B8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/193229681000400614","article-title":"Contribution of an intrinsic lag of continuous glucose monitoring systems to differences in measured and actual glucose concentrations changing at variable rates in vitro","volume":"4","author":"Davey","year":"2010","journal-title":"J Diabetes Sci Technol"},{"issue":"suppl 1","key":"2026092919063946600_zxag252-B9","first-page":"S128","article-title":"Glycemic goals and hypoglycemia: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association","year":"2024","journal-title":"Diabetes Care"},{"key":"2026092919063946600_zxag252-B10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1932296819870849","article-title":"Cutaneous complications with continuous or flash glucose monitoring use: systematic review of trials and observational studies","volume":"14","author":"Asarani","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2026092919063946600_zxag252-B11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/cd17-0053","article-title":"Adoption barriers for continuous glucose monitoring and their potential reduction with a fully implanted system: results from patient preference surveys","volume":"36","author":"Engler","year":"2018","journal-title":"Clin Diabetes"},{"key":"2026092919063946600_zxag252-B12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/dc19-1354","article-title":"Prevalence and prevention of contact dermatitis caused by FreeStyle Libre: a monocentric experience","volume":"43","author":"Pyl","year":"2020","journal-title":"Diabetes Care"},{"key":"2026092919063946600_zxag252-B13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcjd.2020.11.009","article-title":"Scarlet fever after Streptococcus pyogenes skin infection associated with FreeStyle Libre glucose monitoring","volume":"45","author":"Dyminska","year":"2021","journal-title":"Can J Diabetes"},{"key":"2026092919063946600_zxag252-B14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/qjmed\/hcaa123","article-title":"Streptococcus pyogenes necrotizing soft tissue infection following glucose monitoring with FreeStyle Libre device","volume":"114","author":"Von Tokarski","year":"2021","journal-title":"QJM"},{"issue":"5","key":"2026092919063946600_zxag252-B15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7861\/CM-2022-0199.R1","article-title":"Continuous glucose monitoring for diabetes: potential pitfalls for the general physician","volume":"22","author":"Herrod","year":"2022","journal-title":"Clin Med (Lond)"},{"key":"2026092919063946600_zxag252-B16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00592-020-01601-w","article-title":"Bacterial strains colonizing the sensor electrodes of a continuous glucose monitoring system in children with diabetes","volume":"58","author":"Seget","year":"2021","journal-title":"Acta Diabetol"},{"issue":"1","key":"2026092919063946600_zxag252-B17","doi-asserted-by":"publisher","first-page":"e000037","DOI":"10.1136\/bmjdrc-2014-000037","article-title":"Performance of the Medtronic Sentrino continuous glucose management system in the cardiac intensive care unit","volume":"2","author":"Kosiborod","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2026092919063946600_zxag252-B18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13613-016-0167-z","article-title":"Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial","volume":"6","author":"Wollersheim","year":"2016","journal-title":"Ann Intensive Care"},{"key":"2026092919063946600_zxag252-B19","author":"Medtronic"},{"key":"2026092919063946600_zxag252-B20","doi-asserted-by":"crossref","first-page":"e200396","DOI":"10.1001\/jamanetworkopen.2020.0396","article-title":"Comparison of rates of central line\u2013associated bloodstream infections in patients with 1 vs 2 central venous catheters","volume":"3","author":"Dube","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026092919063946600_zxag252-B21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00134-024-07664-5","article-title":"Central venous catheter insertion site and infection prevention in 2024","volume":"50","author":"De Grooth","year":"2024","journal-title":"Intensive Care Med"},{"key":"2026092919063946600_zxag252-B22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/dom.14630","article-title":"Where can you wear your Libre? Using the FreeStyle Libre continuous glucose monitor on alternative sites","volume":"24","author":"Hall","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2026092919063946600_zxag252-B23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1177\/19322968231194643","article-title":"Alternative site of real-time continuous glucose monitoring sensor application for abdominal surgery in the infraclavicular region","volume":"17","author":"Voglov\u00e1 Hagerf","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"2026092919063946600_zxag252-B24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag252\/70832242\/zxag252.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag252\/70832242\/zxag252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:06:43Z","timestamp":1790723203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag252\/8772776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag252","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"zxag252"}}